Professor Rebecca Reynolds and Prof Daniel Smith have partnered with colleagues at the University of Birmingham to commence ENERGISE-BD, a major new clinical trial funded by Wellcome. Full story on Hub for Metabolic Psychiatry webpages Tags 2026 This article was published on Thursday 5 February 2026